Corporate Tech Investors

Medicis Pharmaceutical

Medicis Pharmaceutical is a corporate VC investing group that partners with firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and podiatric conditions and aesthetics medicine. The Company is dedicated to helping patients attain a healthy and youthful appearance and self-image. Medicis has leading branded prescription products in a number of therapeutic categories, including acne, fungal infections, psoriasis, rosacea, seborrheic dermatitis, and skin and skin-structure infections. Additionally, the company markets the leading dermal filler in the U.S., Restylane.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/12/2007

Transaction History

Our records indicate that Medicis Pharmaceutical invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Joseph Papa

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Medicis Pharmaceutical has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Medical Mutual Insurance Company | Medidata Solutions

Share this article

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary